Last reviewed · How we verify
NCT06243471: HAV-EHL-MIS
Hallux Abductus Valgus and Extensor Hallux Longus; Treatment by MIS Surgery
trial testing Minimally invasive procedures for the Hallux Abductus Valgus. in Hallux Valgus and Bunion in 30 participants. Completed in 12 February 2025.
1 February 2025
Quick facts
| Lead sponsor | Fundación Universidad Católica de Valencia San Vicente Mártir |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 February 2024 |
| Primary completion | 1 February 2025 |
| Estimated completion | 12 February 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Minimally invasive procedures for the Hallux Abductus Valgus.
- Minimally invasive procedures for the Hallux Abductus Valgus and a zig-zag tenotomy for the extensus hallux longus.
Conditions studied
- Hallux Valgus and Bunion — all drugs for Hallux Valgus and Bunion →
Sponsor
Fundación Universidad Católica de Valencia San Vicente Mártir — full company profile →
Who can join
Adults 20 to 90, any sex, with Hallux Valgus and Bunion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to investigate the relationship between Hallux Abductus Valgus (HAV) and the hyperextension of the Extensor Hallucis Longus (EHL) tendon. The study aims to understand the efficacy of MIS surgery in treating foot deformities like HAV and to evaluate the impact of EHL tendon hyperextension on this condition. The main questions this study aims to answer are: * How does the hyperextension of the EHL tendon correlate with the presence and severity of HAV? * What is the effectiveness of MIS surgery in correcting HAV deformities and addressing issues related to EHL tendon hyperextension? Participants in this study will undergo pre-surgical evaluation to assess the severity of HAV and measure the extent of EHL tendon hyperextension using pressure platform analysis and other relevant clinical measures. During the MIS surgery, participants will receive treatment targeted at correcting HAV, possibly involving partial tenotomy. If there is a comparison group: Researchers will compare individuals who undergo MIS surgery for HAV correction with a control group not receiving this intervention. The comparison aims to assess the effects of MIS surgery on both HAV correction and the relationship between EHL tendon hyperextension and the deformity. This study endeavors to shed light on the relationship between HAV and EHL tendon hyperextension, the effectiveness of MIS surgery in addressing these issues, and potentially pave the way for improved surgical techniques in treating foot pathologies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Multimodal evaluation of partial zig-zag tenotomy of the extensor hallucis longus in minimally invasive hallux valgus surgery: a randomized trial.
Sanchís-Soria V, Ferrer-Torregrosa J, Marti-Martinez LM, Carratalà-Villarroya G, et al · · 2025 · PMID 41316331 · DOI 10.1186/s13018-025-06456-x
Verify or expand the search:
- PubMed search for NCT06243471
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Fundación Universidad Católica de Valencia San Vicente Mártir trials
Trials by the same sponsor.
- NCT07282236 — Retrospective Comparative Outcomes of Gamma and InterTAN Nail for Unstable Intertrochanteric Hip Fractures · completed
- NCT06818201 — Effects of tDCS on Motor Cortex During ACL Recovery · NA · recruiting
- NCT06932406 — Orofacial Pain Self-management: Personality Moderation Effect · NA · recruiting
- NCT06969456 — Managing Chronic Spinal Pain With Exercise and Neuromodulation · NA · recruiting
- NCT07004543 — Evaluation of Toe Separators in Foot Health · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06243471 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Universidad Católica de Valencia San Vicente Mártir
- Last refreshed: 17 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06243471.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing